Market revenue in 2023 | USD 83.6 million |
Market revenue in 2030 | USD 227.8 million |
Growth rate | 15.4% (CAGR from 2023 to 2030) |
Largest segment | Neurorobotics |
Fastest growing segment | Wearable devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Neurorobotics, Brain-computer interface, Wearable devices, Non-invasive Stimulators |
Key market players worldwide | Bioventus Inc Class A, Tokyo Electron Ltd, Medtronic PLC, IDEX Biometrics ASA, Bionik Laboratories Corp, Bioceres Crop Solutions Corp, Ekso Bionics Holdings Inc, Kinovo PLC, Abbott Laboratories |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to neurorehabilitation devices market will help companies and investors design strategic landscapes.
Neurorobotics was the largest segment with a revenue share of 36.24% in 2023. Horizon Databook has segmented the Canada neurorehabilitation devices market based on neurorobotics, brain-computer interface, wearable devices, non-invasive stimulators covering the revenue growth of each sub-segment from 2018 to 2030.
In terms of prevalence and incidence of neurological disorders, Canada is the most promising market for neurological rehabilitation devices. With key companies, such as Bionik Laboratories and Kinova Robotics, engaged in manufacturing & distribution of neurorehabilitation devices, Canada provides rising growth opportunities for neurorehabilitation devices market.
According to Heart & Stroke Foundation Canada, more than 400,000 Canadians suffer from long-term stroke disability. In 2012, more than 13,000 Canadians died due to stroke. Canada has the highest prevalence of multiple sclerosis in the world, with around 100,000 people estimated to be suffering from the disease.
Also, around 55,000 people are suffering from Parkinson’s disease. The adoption of neurorehabilitation treatments is expected to grow in Canada, as many treatments are covered under medical insurance and the average out-of-pocket expenses are high.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada neurorehabilitation devices market , including forecasts for subscribers. This country databook contains high-level insights into Canada neurorehabilitation devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account